Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

The Utility of Expert Diagnosis in Surgical Neuropathology: Analysis of Consultations Reviewed at 5 National Comprehensive Cancer Network Institutions.

Bruner JM, Louis DN, McLendon R, Rosenblum MK, Archambault WT, Most S, Tihan T.

J Neuropathol Exp Neurol. 2017 Mar 1;76(3):189-194. doi: 10.1093/jnen/nlw122.

PMID:
28395084
2.

Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype.

Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, Thomas G, Zhou S, Wang Q, Elakkad A, Liebelt BD, Yaghi NK, Ezhilarasan R, Huang N, Weinberg JS, Prabhu SS, Rao G, Sawaya R, Langford LA, Bruner JM, Fuller GN, Bar-Or A, Li W, Colen RR, Curran MA, Bhat KP, Antel JP, Cooper LJ, Sulman EP, Heimberger AB.

JCI Insight. 2016;1(2). pii: 85841. doi: 10.1172/jci.insight.85841. Epub 2016 Feb 25.

3.

Adult brainstem gliomas: Correlation of clinical and molecular features.

Theeler BJ, Ellezam B, Melguizo-Gavilanes I, de Groot JF, Mahajan A, Aldape KD, Bruner JM, Puduvalli VK.

J Neurol Sci. 2015;353(1-2):92-7. doi: 10.1016/j.jns.2015.04.014. Epub 2015 Apr 18.

4.

Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?

Melguizo-Gavilanes I, Bruner JM, Guha-Thakurta N, Hess KR, Puduvalli VK.

J Neurooncol. 2015 May;123(1):141-50. doi: 10.1007/s11060-015-1774-5. Epub 2015 Apr 18.

5.

Extraskeletal myxoid chondrosarcoma presenting as an intradural spinal mass: report of a rare clinical presentation with an emphasis on differential diagnostic considerations.

Rao P, Colen RR, Bruner JM, Meis JM.

Rare Tumors. 2014 Dec 18;6(4):5586. doi: 10.4081/rt.2014.5586. eCollection 2014 Oct 27.

6.

Adult pilocytic astrocytomas: clinical features and molecular analysis.

Theeler BJ, Ellezam B, Sadighi ZS, Mehta V, Tran MD, Adesina AM, Bruner JM, Puduvalli VK.

Neuro Oncol. 2014 Jun;16(6):841-7. doi: 10.1093/neuonc/not246. Epub 2014 Jan 26.

7.

Transsphenoidal removal of intrasellar pilocytic astrocytoma.

Prashant Prasad G, Lang FF, Bruner JM, Ater JL, McCutcheon IE.

J Clin Neurosci. 2014 Jun;21(6):1047-8. doi: 10.1016/j.jocn.2013.10.004. Epub 2013 Oct 23.

PMID:
24308951
8.

Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas.

Ellezam B, Theeler BJ, Walbert T, Mammoser AG, Horbinski C, Kleinschmidt-DeMasters BK, Perry A, Puduvalli V, Fuller GN, Bruner JM, Aldape KD.

Acta Neuropathol. 2012 Sep;124(3):449-51. doi: 10.1007/s00401-012-1011-7. Epub 2012 Jul 8. No abstract available.

9.

Anaplastic oligodendroglioma involving the subcutaneous tissue of the scalp: report of an exceptional case and review of the literature.

McLemore MS, Bruner JM, Curry JL, Prieto VG, Torres-Cabala CA.

Am J Dermatopathol. 2012 Apr;34(2):214-9. doi: 10.1097/DAD.0b013e318230655c. Review.

PMID:
22157246
10.

Large oculomotor schwannoma presenting as a parasellar mass: A case report and literature review.

Prabhu SS, Bruner JM.

Surg Neurol Int. 2010 May 31;1:15. doi: 10.4103/2152-7806.63910.

11.

Inhibition of gliomagenesis and attenuation of mitotic transition by MIIP.

Ji P, Smith SM, Wang Y, Jiang R, Song SW, Li B, Sawaya R, Bruner JM, Kuang J, Yu H, Fuller GN, Zhang W.

Oncogene. 2010 Jun 17;29(24):3501-8. doi: 10.1038/onc.2010.114. Epub 2010 Apr 26.

PMID:
20418911
12.

99mTc-sestamibi scan differentiates tumor from other contrast enhancing tissue in choroid plexus tumors.

Subbiah V, Ketonen L, Bruner JM, Nunez R, Weinberg J, Wolff JE.

J Pediatr Hematol Oncol. 2010 Mar;32(2):160-2. doi: 10.1097/MPH.0b013e3181cb85a7.

PMID:
20168252
13.

IIp45 inhibits cell migration through inhibition of HDAC6.

Wu Y, Song SW, Sun J, Bruner JM, Fuller GN, Zhang W.

J Biol Chem. 2010 Feb 5;285(6):3554-60. doi: 10.1074/jbc.M109.063354. Epub 2009 Dec 12.

14.

IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas.

Moore LM, Holmes KM, Smith SM, Wu Y, Tchougounova E, Uhrbom L, Sawaya R, Bruner JM, Fuller GN, Zhang W.

Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16675-9. doi: 10.1073/pnas.0900807106. Epub 2009 Sep 16.

15.

Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience.

Cox JD, Giralt SA, Veazie ML, Ajani JA, Bruner JM, Chan KW, Hittelman WN, Hunt KK, Iyer RB, Karp DD, Kuban DA, Lippman SM, Raad II, Rodriguez-Bigas MA, Zwelling LA, Markman M.

Oncology. 2009;77(2):75-81. doi: 10.1159/000226772. Epub 2009 Jul 1.

16.

Issues of diagnostic review in brain tumor studies: from the Brain Tumor Epidemiology Consortium.

Davis FG, Malmer BS, Aldape K, Barnholtz-Sloan JS, Bondy ML, Brännström T, Bruner JM, Burger PC, Collins VP, Inskip PD, Kruchko C, McCarthy BJ, McLendon RE, Sadetzki S, Tihan T, Wrensch MR, Buffler PA.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):484-9. doi: 10.1158/1055-9965.EPI-07-0725.

17.

The descriptive epidemiology of craniopharyngioma.

Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM.

Neurosurg Focus. 1997 Dec 15;3(6):e1.

PMID:
17206775
18.

Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays.

Jiang R, Mircean C, Shmulevich I, Cogdell D, Jia Y, Tabus I, Aldape K, Sawaya R, Bruner JM, Fuller GN, Zhang W.

Proteomics. 2006 May;6(10):2964-71.

PMID:
16619307
19.

Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.

Fuller GN, Mircean C, Tabus I, Taylor E, Sawaya R, Bruner JM, Shmulevich I, Zhang W.

Oncol Rep. 2005 Sep;14(3):651-6.

PMID:
16077969
20.

TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation.

Puduvalli VK, Sampath D, Bruner JM, Nangia J, Xu R, Kyritsis AP.

Apoptosis. 2005 Jan;10(1):233-43.

21.

Cowden disease with Lhermitte-Duclos disease: case report.

Prabhu SS, Aldape KD, Bruner JM, Weinberg JS.

Can J Neurol Sci. 2004 Nov;31(4):542-9. Review.

PMID:
15595264
22.

The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria.

Ribalta T, McCutcheon IE, Aldape KD, Bruner JM, Fuller GN.

Am J Surg Pathol. 2004 Nov;28(11):1532-6.

PMID:
15489659
23.

Textiloma (gossypiboma) mimicking recurrent intracranial tumor.

Ribalta T, McCutcheon IE, Neto AG, Gupta D, Kumar AJ, Biddle DA, Langford LA, Bruner JM, Leeds NE, Fuller GN.

Arch Pathol Lab Med. 2004 Jul;128(7):749-58.

PMID:
15214828
24.

Six cities revisited.

Bruner JM.

N Engl J Med. 2004 Apr 8;350(15):1577. No abstract available.

PMID:
15071138
25.

Giant cell ependymoma of the spinal cord. Case report and review of the literature.

Fourney DR, Siadati A, Bruner JM, Gokaslan ZL, Rhines LD.

J Neurosurg. 2004 Jan;100(1 Suppl Spine):75-9.

PMID:
14748579
26.

Consistency of primary brain tumor diagnoses and codes in cancer surveillance systems.

Castillo MS, Davis FG, Surawicz T, Bruner JM, Bigner S, Coons S, Bigner DD.

Neuroepidemiology. 2004 Jan-Apr;23(1-2):85-93.

PMID:
14739573
27.

Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival.

Puduvalli VK, Hashmi M, McAllister LD, Levin VA, Hess KR, Prados M, Jaeckle KA, Yung WK, Buys SS, Bruner JM, Townsend JJ, Davis R, Sawaya R, Kyritsis AP.

Oncology. 2003;65(3):259-66.

PMID:
14657600
28.

Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results.

Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S, Berger MS, McDermott MW, Kunwar SM, Junck LR, Chandler W, Zwiebel JA, Kaplan RS, Yung WK.

J Clin Oncol. 2003 Jul 1;21(13):2508-18.

PMID:
12839017
29.

Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.

Levin VA, Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK, Prados MD, Bruner JM, Ictech S, Gleason MJ, Kim HW.

Clin Cancer Res. 2003 Mar;9(3):981-90.

30.

Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group.

Jennings MT, Sposto R, Boyett JM, Vezina LG, Holmes E, Berger MS, Bruggers CS, Bruner JM, Chan KW, Dusenbery KE, Ettinger LJ, Fitz CR, Lafond D, Mandelbaum DE, Massey V, McGuire W, McNeely L, Moulton T, Pollack IF, Shen V.

J Clin Oncol. 2002 Aug 15;20(16):3431-7.

PMID:
12177103
31.

Genetic abnormalities in oligodendroglial and ependymal tumours.

Goussia AC, Kyritsis AP, Mitlianga P, Bruner JM.

J Neurol. 2001 Dec;248(12):1030-5. Review.

PMID:
12013578
32.

Unusual small choroid plexus cyst obstructing the foramen of monroe: case report.

Radaideh MM, Leeds NE, Kumar AJ, Bruner JM, Sawaya R.

AJNR Am J Neuroradiol. 2002 May;23(5):841-3.

33.

Consensus Conference on Brain Tumor Definition for registration. November 10, 2000.

McCarthy BJ, Surawicz T, Bruner JM, Kruchko C, Davis F.

Neuro Oncol. 2002 Apr;4(2):134-45. doi: 10.1093/neuonc/4.2.134. Review.

35.

Gamma-radiation sensitivity and risk of glioma.

Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, Bruner JM, Levin VA, Alfred Yung WK, Adatto P, Wei Q.

J Natl Cancer Inst. 2001 Oct 17;93(20):1553-7.

PMID:
11604478
36.

Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994.

Surawicz TS, McCarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG.

Neuro Oncol. 1999 Jan;1(1):14-25. doi: 10.1093/neuonc/1.1.14.

37.

Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.

Shono T, Tofilon PJ, Bruner JM, Owolabi O, Lang FF.

Cancer Res. 2001 Jun 1;61(11):4375-81.

38.

Adenocarcinoma of the salivary gland metastatic to the pituitary gland: case report.

McCutcheon IE, Kitagawa RH, Sherman SI, Bruner JM.

Neurosurgery. 2001 May;48(5):1161-5; discussion 1165-6. Review.

PMID:
11334286
39.

Risk assessment for developing gliomas: a comparison of two cytogenetic approaches.

El-Zein R, Bondy ML, Wang LE, de Andrade M, Sigurdson AJ, Bruner JM, Kyritsis AP, Levin VA, Wei Q.

Mutat Res. 2001 Jan 25;490(1):35-44.

PMID:
11152970
40.

Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.

Levin VA, Uhm JH, Jaeckle KA, Choucair A, Flynn PJ, Yung WKA, Prados MD, Bruner JM, Chang SM, Kyritsis AP, Gleason MJ, Hess KR.

Clin Cancer Res. 2000 Oct;6(10):3878-84.

41.

Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survival.

Puduvalli VK, Kyritsis AP, Hess KR, Bondy ML, Fuller GN, Kouraklis GP, Levin VA, Bruner JM.

Int J Oncol. 2000 Nov;17(5):963-9.

PMID:
11029499
42.

Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling.

Caskey LS, Fuller GN, Bruner JM, Yung WK, Sawaya RE, Holland EC, Zhang W.

Histol Histopathol. 2000 Jul;15(3):971-81. doi: 10.14670/HH-15.971. Review.

PMID:
10963139
43.

Cytogenetic and molecular genetic abnormalities in primitive neuroectodermal tumors of the central nervous system.

Goussia AC, Bruner JM, Kyritsis AP, Agnantis NJ, Fuller GN.

Anticancer Res. 2000 Jan-Feb;20(1A):65-73. Review.

PMID:
10769636
44.

Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling.

Fuller GN, Rhee CH, Hess KR, Caskey LS, Wang R, Bruner JM, Yung WK, Zhang W.

Cancer Res. 1999 Sep 1;59(17):4228-32.

45.

A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.

Groves MD, Maor MH, Meyers C, Kyritsis AP, Jaeckle KA, Yung WK, Sawaya RE, Hess K, Bruner JM, Peterson P, Levin VA.

Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):127-35.

PMID:
10477016
46.

Increased chromosomal instability in peripheral lymphocytes and risk of human gliomas.

El-Zein R, Bondy ML, Wang LE, de Andrade M, Sigurdson AJ, Bruner JM, Kyritsis AP, Levin VA, Wei Q.

Carcinogenesis. 1999 May;20(5):811-5.

PMID:
10334198
47.

The descriptive epidemiology of craniopharyngioma.

Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM.

J Neurosurg. 1998 Oct;89(4):547-51.

PMID:
9761047
48.

Sulfonylurea receptor mRNA expression in pituitary macroadenomas.

Zhu Z, McCutcheon IE, Lopes MB, Laws ER Jr, Wagner VL, Bruner JM, Fuller GN, Langford LA, Ang LW, Friend KE.

Endocrine. 1998 Feb;8(1):7-12.

PMID:
9666339
49.

Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas.

Trizna Z, de Andrade M, Kyritsis AP, Briggs K, Levin VA, Bruner JM, Wei Q, Bondy ML.

Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):553-5.

50.

Identification of allelic loss on chromosome arm 6p in human astrocytomas by arbitrarily primed polymerase chain reaction.

Saitoh Y, Bruner JM, Levin VA, Kyritsis AP.

Genes Chromosomes Cancer. 1998 Jul;22(3):165-70.

PMID:
9624527

Supplemental Content

Loading ...
Support Center